Conventional surface water treatment plants (WTPs) rely on optimised coagulation for effective clarification, filtration and chlorination performance. WTPs operated at sub-optimal coagulation conditions are at risk from failing treated water microbial, disinfection by-product, chemical and aesthetic quality goals as well as incurring excessive sludge production and treatment cost. This is especially important when treating water that contains a high concentration of natural organic matter (NOM). Removal of NOM by coagulation can be enhanced by optimising the inorganic coagulant dose and coagulation pH. This paper describes the development and implementation of a software model mEnCo q (referring to modelling enhanced coagulation) that enables WTP operators to rapidly determine coagulation chemicals. Implementation was carried out in a fourstage process comprising model evaluation by (1) jar tests and pilot-scale studies, (2) comparison of mEnCo q predictions with historical water quality and coagulant dose trends at Adelaide metropolitan WTPs, (3) parallel studies where mEnCo q predictions were compared with the usual methods applied by operators for chemical dose determination and (4) application of mEnCo q for dose determination and review. United Water International (UWI) began using mEnCo q in July 2003 for prediction of chemical doses for coagulation control and have used the model from July 2004 to adjust coagulant doses. by guest J. van Leeuwen et al. | Development and implementation of the software mEnCo q
INTRODUCTION
Commonly used metal-based coagulants at WTPs include alum and ferric chloride and both are able to remove high percentages of colour and turbidity and various percentages of natural organic matter (NOM), depending on its character. It is important to control the concentration of dissolved organic carbon (DOC) in finished water as it has a major impact on water quality and the performance of downstream treatment processes. It is the precursor to disinfection by-products including trihalomethanes (THMs); it imparts a chlorine demand; it provides nutrients for heterotrophic bacterial re-growth; it reduces the effectiveness of activated carbon and it leads to fouling of membranes.
DOC removal using metal coagulants is dependent upon its concentration and character as well as the coagulant type and dose, and the coagulation pH (Edzwald 1992) . The DOC that is removed by coagulation is the coagulable fraction and the DOC that is recalcitrant to coagulation can be referred to as being non-coagulable (van Leeuwen et al. 2005) . These fractions, in the case of alumand ferric-based coagulants, are pH-dependent. The coagulable DOC comprises organics that are hydrophobic, charged, high in molecular weight and absorb light in the UV and visible wavelength spectrum. The relative levels of UV254 nm (SUVA) and colour (specific colour) in raw water indicate the DOC removal potential using metal coagulants (Chow et al. 1999) .
Both alum and ferric coagulants are acidic and will lower the pH of raw water. The coagulation pH can be modified by the addition of acid or base and requires control to minimize soluble metal residuals in the treated water. For example, aluminium solubility increases sharply at a pH less than 5.7 and, allowing a margin of safety, the optimum pH for alum is 6.0 and slightly lower for ferric coagulants (Letterman et al. 1999) .
In practice, a number of factors should be considered when optimizing coagulation for DOC removal, including treatment cost, sludge production and water quality (Heidenreich et al. 2002) . Water quality goals may include turbidity and particle removal (Budd et al. 2004 
MATERIALS AND METHODS

Water supply and treatment in Adelaide
Adelaide's raw water is supplied from local catchments and 2001, 2005) .
Examples of the mathematical relationships between DOC
(as measured and characterised by UV at 254 nm/cm and colour) and coagulant dose required for enhanced coagulation are given below:
Dose
where A 1 , B 1 , C 1 , A 2 , B 2 and C 2 are constants and UVCol is UV254 £ log(colour £ 10).
Separate mathematical relations have been developed
that relate raw water turbidity to coagulant dose and these have been previously reported (van Leeuwen et al. 2001 (van Leeuwen et al. , 2003 . Once the dose is calculated it is then added to the dose determined to be required based on the DOC concentration and character. Hence, the two parameters of DOC and turbidity are treated as independent variables. Although it is likely that there is some interdependence of the two variables on the coagulant dose, the application of these as independent variables has been found to be practically applicable based on jar test and pilot The generic function in mEnCo q is intended to enable rapid prediction of: † the alum or ferric chloride dose rate required to achieve a user-specified reduction in coagulable DOC in the range 50-90% without pH control; † the alum or ferric chloride dose rate required to achieve enhanced coagulation without pH control; † the alum or ferric chloride dose rate plus acid or alkali dose required to achieve a given percentage removal of Target conditions that require a higher pH require base addition and sodium hydroxide dose rates can also be predicted. Implementation of mEnCo q into UWI operations was carried out in a four-stage process comprising of:
(1) model evaluation by jar tests and pilot-scale studies,
(2) comparison of mEnCo q predictions with historical water quality and coagulant dose trends at Adelaide metropolitan WTPs, (3) parallel studies where mEnCo q predictions were compared with the usual methods applied by operators for chemical dose determination, i.e. jar testing, and (4) application of mEnCo q for chemical dose determination and review.
Model validation trials
Pilot plant trials using flat bed clarifiers, ranging in capacity from 800 L/h to 3700 L/h, were undertaken to validate mEnCo q predictions at Happy Valley, Anstey Hill and Middle River WTPs in South Australia and at the Googong WTP, ACT. The results of these trials have been previously reported (Holmes et al. 2006) . 2003) was used as input data for mEnCo q . Results from this study revealed several findings. It was apparent that the alum dose rates predicted by mEnCo q were in the range used at the WTPs. The study also indicated periods when the WTPs had been operated with a lower or higher alum dose as compared to the mEnCo q enhanced coagulation predicted alum dose. This study did suggest that the application of mEnCo q could lead to opportunities for savings in chemical costs as well as improved water quality.
RESULTS AND DISCUSSION
Jar tests were used during this period to assist operators establish alum dose rates at a frequency of one every two months, or sooner if sudden changes in raw water quality were experienced. The study also investigated the performance of the model in predicting coagulation pH. In general mEnCo q gave a reasonably accurate prediction of the coagulation pH (range in difference 0 -0.25 pH).
Implementation of mEnCo q into operations
UWI began using mEnCo q in July 2003 to predict the required alum dose to achieve 80% and 90% coagulable DOC removal and enhanced coagulation. Figure 1 (Figure 1(b) ), are operated using alum doses that achieve between 80% and 90% coagulable DOC removal, as predicted by mEnCo q .
Prior to the introduction of mEnCo q significant over-or The source water to the WTP may be changed from one source to another at very little notice and it may not be possible to obtain a sample of the new raw water in time to undertake a jar test prior to the new water reaching the plant. Under these circumstances application of mEnCo q predicted alum doses has resulted in water quality remaining within specification during the change in source water (Figure 2(a) ).
Coagulant and chlorine dose rates are applied at the water treatment plants to achieve water quality guidelines (Australian Drinking Water Guidelines [ADWG] 2004) and license requirements from the South Australian Water Corporation for coliforms, THMs and free-chlorine residual at the customer tap. WTPs are also operated to achieve low filtered water turbidity (,0.1 NTU) and low aluminium residual (, 0.2 mg/L) . Prior to implementation of mEnCo q , jar tests were used as a tool to select alum dose rates at metropolitan Adelaide WTPs. During this time water quality was fully compliant with contractual and ADWG requirements at the WTPs and in the network. Full compliance has also been achieved using mEnCo q .
However, reliance on mEnCo q alone is not appropriate for controlling coagulant dosing at these plants. The optimal coagulant dose for DOC removal may, for instance, not be the optimal dose for particle removal, where particle removals and residuals form treatment and treated water quality requirements. Depending on plant design and hydraulics, the application of mEnCo q may lead to insufficient development of flocs needed for effective clarification. At times it has been necessary for an individual plant to use an alum dose in excess of that predicted by mEnCo q due to poor floc formation at the MPD. An example is the Myponga WTP during the late summer and autumn of 2006 (Figure 2(b) ). The water treated by the Myponga WTP is very high in DOC but low in turbidity and, due to both water quality and plant design, the floc produced was small, weak and difficult to remove through the flotation process. At this time the flotation process was not operating effectively when alum was dosed at the MPD.
The dose was therefore increased above the MPD for a sixmonth period until raw water quality had changed to the extent that the MPD again produced a treatable floc. The exact reason is unknown. This highlights the importance of maintaining vigilance at the WTP and continuing to monitor parameters such as settled/floated water and filtered water turbidity to ensure that the plant is operating as required at the MPD. Similar vigilance must be maintained to monitor key performance indicators in the WDS.
Recently published work (Budd et al. 2004; Holmes et al. 2004 ) has also shown that maximum removal of particles through a WTP may require higher coagulant doses than are required for optimum DOC removal. mEnCo q has also been assessed for use at two UWI operated WTPs in Ballarat, Victoria, Australia. These plants have a contractual requirement to produce filtered water with a particle count of less than 100 particles per mL in the 2-15mm size range.
Experience at these plants has indicated that, if the plant were operated at the coagulant doses predicted by mEnCo q for maximum DOC removal, then the particle counts may at times exceed that contractual limit. Higher alum doses are required to ensure that the particle count target is achieved.
Therefore the mEnCo q predicted results require interpretation when fine-tuning the operation of WTPs. Actual coagulant doses may be required to be higher than mEnCo q predicted doses to compensate for inadequate WTP design that may give rise to poor mixing, inappropriate contact times and short circuiting.
Prediction of pH correction chemical dose
Barossa WTP is the only metropolitan Adelaide WTP with the capacity to dose sulfuric acid in order to obtain an optimum coagulation pH. Therefore the plant has the capacity to reduce alum dose and increase sulfuric acid dose while maintaining the optimum coagulation pH. This facility is useful as this plant has limited sludge treatment facilities and lower alum doses result in reduced sludge production. mEnCo q can be used to determine the additional acid dose required to achieve the target coagulation pH (6.1) for a range in alum dose rates (Figure 3) .
Use of mEnCo q as a design tool
With the confidence gained from its application at the six WTPs, mEnCo q has been used as a design tool to determine potential coagulant and pH correction chemical doses for a proposed new WTP in South Australia. UWI was contracted to determine the design parameters for a proposed WTP to treat water from Wirrina Reservoir, a privately owned and operated water supply in South Australia. The existing WTP does not use coagulation and no jar test or historical water quality data was available to determine either treatability of the water or potential required coagulant doses. A 12-month monitoring programme was initiated to provide raw water quality data, including colour, turbidity, UV254 and alkalinity. This data was used in conjunction with mEnCo q to predict the alum and ferric doses for a range of different DOC removals (Figure 4(a) ), as well as the doses of pH correction chemical needed to obtain the required coagulation pH (Figure 4(b) ). This allowed an estimation of the required chemical storage and dosing requirements for the proposed new plant as well as an economic comparison of the different coagulants. Application of any model needs to be assessed on the basis of achieving the required treated water quality and this varies between countries and potentially between their states and territories. Hence, application requires assessment for suitability and potentially modification according to site-specific water quality conditions and treatment systems that exist. As detailed in this paper, application of models and software involves testing for suitability to assess the reliability and accuracy of dose predictions. The benefits are that, once established, they can provide significant labour, cost and time savings by removing the need for frequent jar testing, and enable rapid response to source water quality changes. water quality. It has reduced the need to undertake jar tests and has enabled coagulation processes to be optimised for both DOC removal and chemical cost. This has allowed for water supply of improved quality to customers in Adelaide that is cost effective. mEnCo q has also been used as a design tool and has proved to be particularly valuable when designing new coagulation and pH correction dosing facilities.
